These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2696902)

  • 1. Prenatal narcotic exposure: perinatal and developmental effects.
    Kaltenbach KA; Finnegan LP
    Neurotoxicology; 1989; 10(3):597-604. PubMed ID: 2696902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure.
    Choo RE; Huestis MA; Schroeder JR; Shin AS; Jones HE
    Drug Alcohol Depend; 2004 Sep; 75(3):253-60. PubMed ID: 15283946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal nonnarcotic substance abuse during pregnancy: effects on infant development.
    Chasnoff IJ; Schnoll SH; Burns WJ; Burns K
    Neurobehav Toxicol Teratol; 1984; 6(4):277-80. PubMed ID: 6514088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal drug exposure: effects on neonatal and infant growth and development.
    Chasnoff IJ; Burns KA; Burns WJ; Schnoll SH
    Neurobehav Toxicol Teratol; 1986; 8(4):357-62. PubMed ID: 3762846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine.
    Sarfi M; Martinsen H; Bakstad B; Røislien J; Waal H
    Early Hum Dev; 2009 Dec; 85(12):773-8. PubMed ID: 19931991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual evoked potentials in infants exposed to methadone in utero.
    McGlone L; Mactier H; Hamilton R; Bradnam MS; Boulton R; Borland W; Hepburn M; McCulloch DL
    Arch Dis Child; 2008 Sep; 93(9):784-6. PubMed ID: 18305073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
    Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
    J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Substitution treatment of drug addicts during pregnancy: consequences for the children?].
    Sandtorv L; Reigstad H; Bruarøy S; Elgen I; Laegreid LM
    Tidsskr Nor Laegeforen; 2009 Feb; 129(4):287-90. PubMed ID: 19219093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental outcome of children born to methadone maintained women: a review of longitudinal studies.
    Kaltenbach K; Finnegan LP
    Neurobehav Toxicol Teratol; 1984; 6(4):271-5. PubMed ID: 6392916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of maternal opiate abuse on the newborn.
    Finnegan LP
    Fed Proc; 1985 Apr; 44(7):2314-7. PubMed ID: 3884386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants.
    Miles J; Sugumar K; Macrory F; Sims DG; D'Souza SW
    Child Care Health Dev; 2007 Mar; 33(2):206-12. PubMed ID: 17291325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero.
    Hunt RW; Tzioumi D; Collins E; Jeffery HE
    Early Hum Dev; 2008 Jan; 84(1):29-35. PubMed ID: 17728081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A four year survey of neonatal narcotic withdrawal: evaluation and treatment.
    Lifshitz M; Gavrilov V; Galil A; Landau D
    Isr Med Assoc J; 2001 Jan; 3(1):17-20. PubMed ID: 11344794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy.
    Hamilton R; McGlone L; MacKinnon JR; Russell HC; Bradnam MS; Mactier H
    Br J Ophthalmol; 2010 Jun; 94(6):696-700. PubMed ID: 20410537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome.
    Kaltenbach K; Finnegan LP
    Neurobehav Toxicol Teratol; 1986; 8(4):353-5. PubMed ID: 3762845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auditory brainstem-evoked potentials in term infants born to mothers addicted to opiates.
    McPherson DL; Madden JD; Payne TF
    J Perinatol; 1989 Sep; 9(3):262-7. PubMed ID: 2809778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.